{{Rsnum
|rsid=9594782
|Gene=TNFSF11
|Chromosome=13
|position=42577050
|Orientation=plus
|GMAF=0.04775
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TNFSF11
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 0.0 | 13.3 | 86.7
| JPT | 0.0 | 18.6 | 81.4
| YRI | 0.0 | 1.6 | 98.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 13.3 | 86.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20431232
|Title=The relationship between receptor activator of nuclear factor-kappaB ligand (RANKL) gene polymorphism and aortic calcification in Korean women
}}{{PMID|16249885}} Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men.

{{PMID|17002564|OA=1
}} Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction.

{{PMID|19150398|OA=1
}} Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.